The Library
A prospective pilot study of home monitoring in adults with cystic fibrosis (HOME-CF) : protocol for a randomised controlled trial
Tools
Tools
Tools
Choyce, Jocelyn, Shaw, Karen L., Sitch, Alice J., Mistry, Hema, Whitehouse, Joanna L. and Nash, Edward F. (2017) A prospective pilot study of home monitoring in adults with cystic fibrosis (HOME-CF) : protocol for a randomised controlled trial. BMC Pulmonary Medicine, 17 (1). 22. doi:10.1186/s12890-017-0366-x ISSN 1471-2466.
|
PDF
WRAP_Hema_ prospective_pilot_study.pdf - Published Version - Requires a PDF viewer. Available under License Creative Commons Attribution 4.0. Download (936Kb) | Preview |
Official URL: https://doi.org/10.1186/s12890-017-0366-x
Abstract
Background
Home monitoring has the potential to detect early pulmonary exacerbations in people with cystic fibrosis (CF), with consequent improvements in health outcomes and healthcare associated costs. This study aims to assess the effects of home monitoring on hospital admissions, quality of life, antibiotic requirements, exacerbation frequency, lung function, nutritional outcomes, anxiety, depression, costs and health outcomes, as well as the qualitative effects on the patient experience.
Methods
This randomised controlled mixed-methods trial aims to recruit 100 adults with CF cared for in one large regional CF centre. Participants are randomly allocated 1:1 to the intervention group (twice-weekly home monitoring of symptoms measured by the Cystic Fibrosis Respiratory Symptom Diary – Chronic Respiratory Infection Symptom Score (CFRSD-CRISS) and Forced Expiratory Volume in one second (FEV1)) or a control group (routine clinical care) for the 12-month study period. Measurements are recorded at study visits at baseline, 3, 6, 9 and 12 months. Spirometry, body weight, co-morbidities, medications, hospital inpatient days, courses of antibiotics (oral and intravenous), pulmonary exacerbations (defined by the modified Fuchs criteria) are recorded at each study visit. Health status, capability and health economics are measured at each study visit by the Hospital Anxiety and Depression Scale (HADS), the ICEpop CAPability measure for Adults (ICECAP-A), EuroQol 5 dimensions (EQ-5D-5L) questionnaire and an adapted resource use questionnaire. The patient experience is assessed by semi-structured qualitative interviews at baseline and 12 months.
Discussion
Results from this study will help to determine the effect of home monitoring on inpatient bed days and quality of life in adults with CF, as well as other relevant health and health economic outcomes.
| Item Type: | Journal Article | ||||||||
|---|---|---|---|---|---|---|---|---|---|
| Subjects: | R Medicine > RC Internal medicine | ||||||||
| Divisions: | Faculty of Science, Engineering and Medicine > Medicine > Warwick Medical School | ||||||||
| Library of Congress Subject Headings (LCSH): | Cystic fibrosis | ||||||||
| Journal or Publication Title: | BMC Pulmonary Medicine | ||||||||
| Publisher: | BioMed Central Ltd. | ||||||||
| ISSN: | 1471-2466 | ||||||||
| Official Date: | 23 January 2017 | ||||||||
| Dates: |
|
||||||||
| Volume: | 17 | ||||||||
| Number: | 1 | ||||||||
| Article Number: | 22 | ||||||||
| DOI: | 10.1186/s12890-017-0366-x | ||||||||
| Status: | Peer Reviewed | ||||||||
| Publication Status: | Published | ||||||||
| Access rights to Published version: | Open Access (Creative Commons) | ||||||||
| Date of first compliant deposit: | 8 February 2017 | ||||||||
| Date of first compliant Open Access: | 8 February 2017 | ||||||||
| Funder: | National Institute for Health Research (Great Britain) (NIHR), Gilead UK and Ireland Community Grants Programme , Collaborations for Leadership in Applied Health Research and Care (CLAHRC) |
Request changes or add full text files to a record
Repository staff actions (login required)
 |
View Item |
Downloads
Downloads per month over past year
